How to Get Fosamax (Alendronate) in North Carolina

What Is Alendronate and Why Is It Prescribed?

Alendronate is a first-line oral bisphosphonate that slows osteoclast-driven bone resorption, preserving and in some cases modestly rebuilding bone mineral density. The FDA approved the 70 mg once-weekly tablet for postmenopausal osteoporosis in 1995, and it remains one of the most prescribed osteoporosis agents in the United States. [1]

The bisphosphonate binds to hydroxyapatite crystals in bone and is released locally during resorption, where it triggers osteoclast apoptosis. That mechanism sounds straightforward, but the clinical magnitude is significant. In the Fracture Intervention Trial (FIT, N=2,027), three years of alendronate therapy cut the risk of hip fracture by 47% and vertebral fracture by 55% compared with placebo (P<0.001). [2] Those numbers come from a randomized, controlled design published in JAMA in 1998, not from observational estimates.

The National Osteoporosis Foundation (now the Bone Health and Osteoporosis Foundation) guideline recommends pharmacologic therapy for postmenopausal women and men aged 50 and older who have: a hip or spine T-score at or below -2.5, a prior hip or vertebral fracture, or a 10-year FRAX probability of major osteoporotic fracture at or above 20% or hip fracture at or above 3%. [3] Alendronate sits at the top of that algorithm alongside risedronate because of its long safety record and low cost.

Men are eligible too. The FDA approved alendronate 10 mg daily (or 70 mg weekly) for osteoporosis in men in 2000, based on a two-year trial showing a 7.1% increase in lumbar spine BMD versus 1.8% for placebo. [4]

Who Can Prescribe Fosamax in North Carolina?

North Carolina law grants prescribing authority for alendronate to several licensed practitioner types. The prescriber must hold an active North Carolina controlled-substance registration is not required for alendronate (it is not a controlled substance), but a valid NC DEA number for other medications does not restrict them from prescribing bisphosphonates.

The following practitioner categories can legally prescribe alendronate in North Carolina:

Medical Doctors (MD) and Doctors of Osteopathic Medicine (DO). Full prescriptive authority with no supervisory requirement.

Nurse Practitioners (NP). North Carolina is a full practice authority state as of 2023, meaning NPs no longer need a collaborative practice agreement to prescribe. An NP specializing in women's health, internal medicine, or endocrinology can initiate alendronate independently.

Physician Assistants (PA). PAs in NC prescribe under a supervising physician agreement, but that agreement does not need to be in the same room or same encounter. Alendronate is well within the standard scope for a PA in primary care, endocrinology, or orthopedics.

Pharmacist Prescribers. NC allows pharmacist prescribing under a statewide protocol for certain drug classes. Osteoporosis bisphosphonates are not yet listed under that protocol statewide, so a pharmacist cannot initiate alendronate independently without a collaborative practice agreement with a licensed prescriber.

A prescriber of any of the above types who holds an active NC license can write the prescription during a qualifying telehealth visit, ship the Rx electronically to any licensed NC pharmacy, or route it to a mail-order pharmacy that ships into North Carolina.

How North Carolina Telehealth Law Applies to Alendronate

North Carolina telehealth prescribing is governed by the NC Medical Board's position statement on telemedicine, last updated in 2021, and by Session Law 2015-241, which requires commercial insurers to cover telehealth services at parity with in-person visits. [5]

A prescriber can write a new alendronate prescription after a synchronous audio-video telehealth visit that includes a clinical evaluation. "Audio-only" visits (phone calls without video) are permissible for established patients but are typically not sufficient for a new osteoporosis prescription from an online clinic, because the prescriber needs to review imaging reports and discuss fall-risk factors in a documented way that satisfies the NC standard of care.

The practical workflow for a telehealth alendronate visit in NC:

1. The patient uploads a DEXA scan report (within the last 2 years for most protocols, or within 5 years if a prior treatment decision was based on it).
2. The prescriber reviews labs (serum calcium, creatinine, 25-OH vitamin D) either from uploaded records or by ordering them through a partner lab before the visit.
3. A live video visit occurs. The prescriber confirms the diagnosis, calculates FRAX score if not already done, and documents counseling on administration technique and side effects.
4. The Rx is sent electronically to the patient's preferred NC pharmacy or a mail-order pharmacy.

Several national telehealth platforms with NC licensure offer this pathway, including HealthRX. The visit-to-pharmacy turnaround is typically 1, 3 business days once labs are confirmed.

Labs Required Before Starting Alendronate in North Carolina

Specific labs should be completed before the first prescription is written. This is not bureaucratic box-checking. Alendronate is contraindicated in hypocalcemia (any serum calcium below the reference range), and dosing must be adjusted or avoided in patients with creatinine clearance below 35 mL/min. [1]

The standard pre-treatment panel includes:

Serum calcium (corrected for albumin). Hypocalcemia must be corrected before starting any bisphosphonate. The FDA label for alendronate explicitly lists hypocalcemia as a contraindication. [1]

Serum creatinine and eGFR. Alendronate is not recommended when eGFR falls below 35 mL/min/1.73 m² because the drug is renally cleared and accumulates to levels with uncertain safety in advanced chronic kidney disease. The AACE/ACE Clinical Practice Guidelines (2020) specify this threshold. [6]

25-hydroxyvitamin D. Deficiency (below 20 ng/mL) blunts the response to bisphosphonates and worsens the risk of hypocalcemia. Supplementing to at least 30 ng/mL before starting alendronate is standard practice. [6]

DEXA scan (dual-energy X-ray absorptiometry). This is the diagnostic prerequisite, not a lab per se, but every NC prescriber will require a T-score report from an accredited DXA facility before initiating therapy. The FRAX fracture risk calculator also requires BMD input for its most accurate output.

Optional: serum phosphorus, bone-specific alkaline phosphatase, and thyroid function. These are not universally required but may be ordered if the prescriber suspects secondary causes of osteoporosis such as hyperparathyroidism or hyperthyroidism.

Labs ordered at any CLIA-certified lab in North Carolina count. Quest Diagnostics, LabCorp, Labcorp at Walmart, and hospital outpatient labs all qualify. Some telehealth platforms will order labs on your behalf through a partner requisition before the visit, so you arrive with results in hand.

Finding Fosamax or Generic Alendronate at NC Pharmacies

Brand-name Fosamax is manufactured by Merck but is rarely dispensed today. Generic alendronate sodium 70 mg weekly tablets from manufacturers including Teva, Mylan (now Viatris), and Hikma are widely stocked at NC pharmacy chains. Pricing varies:

At CVS, Walgreens, Harris Teeter Pharmacy, and Walmart Pharmacy across North Carolina, the cash price for a 4-tablet (one-month) supply of generic alendronate 70 mg runs approximately $10, $15 without a discount card. GoodRx and similar discount programs bring some NC pharmacy prices below $8 per month.

503A Compounding Pharmacies in North Carolina. A 503A compounding pharmacy (patient-specific, non-sterile or sterile compounding under USP <797> and <795> standards) licensed by the NC Board of Pharmacy can prepare alendronate in alternative dosage forms (for example, an oral solution for patients who cannot swallow tablets or who have documented esophageal dysmotility). The 503A pharmacy requires a valid patient-specific prescription from an NC-licensed prescriber. They cannot compound a commercially available strength (70 mg tablet) without a documented clinical reason, per USP and NCBOP policy. [7]

Mail-order pharmacies shipping to NC. National mail-order pharmacies including CVS Caremark, Express Scripts, and Optum Rx are licensed to ship alendronate to NC addresses. Specialty online pharmacies that dispense pursuant to telehealth visits (such as those partnered with telehealth clinics) are also licensed to ship into the state provided the dispensing pharmacy holds an NC non-resident pharmacy permit from the NCBOP.

Insurance Coverage and Prior Authorization in North Carolina

Most commercial insurance plans in North Carolina cover generic alendronate as a Tier 1 or Tier 2 medication with no prior authorization required. Copays range from $0 to $10 per month on standard formularies.

NC Medicaid (NC Tracks / NCÂ Medicaid Managed Care). The current NC Medicaid Preferred Drug List does not include alendronate for the osteoporosis indication; coverage under NC Medicaid is listed for a type 2 diabetes-adjacent indication only. A prescriber who believes a Medicaid patient medically requires alendronate for osteoporosis can submit a prior authorization (PA) request through the NC Medicaid ePACES portal or through the managed care plan (Blue Cross NC Health Plan, Healthy Blue, WellCare, etc.).

Prior authorization documentation typically required for NC Medicaid:

• DEXA scan report with T-score at or below -2.5, OR
• Documentation of a low-trauma fracture (hip, spine, wrist), PLUS
• Prescriber attestation that the patient has been counseled on calcium and vitamin D supplementation, PLUS
• Proof that the diagnosis meets the BHOF/NOF criteria cited above

The PA review timeline under NC Medicaid managed care plans is generally 72 hours for standard requests and 24 hours for urgent requests per NC DHHS HealthChoice guidelines.

Medicare Part D. Alendronate generic is on virtually all Part D formularies at Tier 1. Patients with a low-income subsidy (LIS/Extra Help) pay $0 to $4 per fill. No PA is required for the 70 mg weekly generic under most plans.

Blue Cross Blue Shield of NC. BCBS NC covers generic alendronate as a Tier 1 drug with a standard $10 copay. No PA is required for the first year of therapy. Ongoing coverage beyond 5 years may prompt a drug-use review query asking the prescriber to document continued clinical rationale, consistent with the BHOF recommendation to reassess after 3 to 5 years of bisphosphonate therapy. [3]

How to Transfer an Existing Fosamax Prescription to North Carolina

Transferring a prescription is straightforward if you are relocating to NC or switching pharmacies.

For retail pharmacy transfers, federal law (21 CFR 1306) and NC pharmacy board rules allow a pharmacist to transfer a remaining refill authorization from one pharmacy to another. You call the new NC pharmacy, give them the original pharmacy's name and phone number and your Rx number, and the pharmacists handle the transfer. Alendronate is non-controlled, so there is no limit on the number of transfers (unlike Schedule III-V controlled substances, which allow only one transfer between non-chain pharmacies).

For transferring care to a new NC prescriber, no formal "transfer" of the prescription is needed. The new prescriber reviews your prior records, confirms the diagnosis, checks current labs, and writes a new Rx. If you are switching from an out-of-state telehealth clinic to an NC-licensed provider, ask your prior clinic to send a clinical summary including the original DEXA report and lab results. That speeds up the new prescriber's chart review and avoids duplicate testing.

Out-of-state prescriptions. An out-of-state prescription for alendronate written by a licensed prescriber from another state is valid at any NC retail pharmacy for the number of fills indicated, provided the prescriber was licensed in their home state at the time of writing and the Rx was written within the past 12 months (most pharmacy systems flag older Rx dates as expired per NC General Statute 90-85.27). [8]

Correct Administration of Alendronate: What NC Patients Must Know

The pharmacology of alendronate makes administration technique more clinically significant than with most oral medications. Poor technique reduces bioavailability and raises the risk of esophageal injury.

The FDA label specifies the following administration protocol, which every NC prescriber is expected to counsel on: [1]

1. Take the 70 mg tablet on the same day each week, first thing in the morning.
2. Swallow the tablet whole with a full 8-ounce glass of plain water. No mineral water, coffee, juice, or other beverages.
3. Remain upright (standing or sitting fully upright) for at least 30 minutes after swallowing. Do not lie down.
4. Do not eat, drink anything other than plain water, or take other oral medications or supplements for at least 30 minutes after the dose.
5. Do not take the tablet at bedtime or before rising for the day.

The Endocrine Society's 2019 clinical practice guideline on osteoporosis in postmenopausal women states directly: "Patients should be instructed on proper administration technique for oral bisphosphonates to minimize the risk of esophageal adverse effects." [9] Esophagitis and, rarely, esophageal ulceration have been reported with improper use, which is why the upright-positioning rule is non-negotiable.

Oral health screening is also relevant. The FDA label and AAOMS position statement note the rare risk of medication-related osteonecrosis of the jaw (MRONJ), primarily associated with high-dose IV bisphosphonate use in oncology patients. The risk with weekly oral alendronate at osteoporosis doses is estimated at 1 in 10,000 to 1 in 100,000 patient-years of exposure. [10] NC prescribers typically recommend completing any needed invasive dental work before starting therapy when possible, not as a requirement to prescribe but as good preventive care.

Monitoring and Drug Holidays After Starting Alendronate

Starting alendronate is not the end of the clinical conversation. Ongoing monitoring shapes the long-term plan.

Year 1 to Year 3. Repeat DEXA scan at 1 to 2 years to confirm bone mineral density is stable or improving. Recheck 25-OH vitamin D and serum calcium at 6 to 12 months to ensure supplementation is adequate.

The Drug Holiday Question. Alendronate incorporates into bone and continues exerting anti-resorptive effects for months to years after discontinuation. The BHOF and AACE both recommend reassessing after 3 to 5 years of therapy for lower-risk patients and considering a drug holiday (typically 1 to 2 years off the drug) while monitoring BMD and bone turnover markers. [6] Higher-risk patients (T-score below -2.5 at the femoral neck, prior fracture history) are typically continued beyond 5 years or switched to a different agent.

Atypical Femur Fractures. Long-term bisphosphonate use (generally beyond 5 years) is associated with a small but real risk of atypical subtrochanteric or diaphyseal femur fractures. The absolute risk is low: the FDA estimates 3.2, 50 cases per 100,000 person-years, depending on duration of use. [1] Patients on long-term therapy who report new thigh or groin pain should have a femur X-ray to rule out a stress reaction.

The annual monitoring visit with a prescriber who reviews DEXA trends, fracture history, and symptom history is the structure that prevents both under-treatment and over-treatment.